Liver function

Ongoing clinical trials and approved products targeting Liver function, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials
1ongoing imaging trials
1approved products

Target note

Full name
Hepatocyte function
Nature
Asialoglycoprotein receptor of hepatocytes.
Normal expression
Liver.
Value
Quantifying the liver reserve before hepatectomy or radioembolisation.
Approaches
[99mTc]GSA, [99mTc]mebrofenin.
Indications explored
Liver surgery, hepatocellular carcinoma.
Points of caution
—

Approved products

[99mTc] hepatobiliary scintigraphy (mebrofenin)[99mTc]mebrofeninMultiplesmarketed (national authorisations)US EU FR

Ongoing imaging trials · 1Open in the radar →

TrialPhaseStatusSponsorCountries
[99mTc]GSA (liver function)NCT07358975 · Solid tumors (multiple indications)No phaseNot yet recruitingCopenhagen University Hospital, Rigshospitalet1

Cite this page

Liver function. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/liver-function/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.